HAE - CIK 0000313143
The table below shows HAEMONETICS CORP's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $363.37M | $296.43M | $292.90M | $320.85M | $299.28M | $344.43M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $195.71M | $207.07M | $200.75M | $211.95M | $213.53M | $201.49M |
| Inventory | $321.19M | $336.21M | $360.53M | $359.61M | $382.11M | $373.79M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $943.67M |
| $899.68M |
| $913.16M |
| $1.01B |
| $955.90M |
| $978.58M |
| Property, plant & equipment | $297.23M | $292.48M | $286.87M | $286.11M | $300.48M | $302.48M |
| Goodwill | $606.83M | $606.10M | $607.30M | $605.27M | $616.16M | $613.35M |
| Total assets | $2.49B | $2.44B | $2.46B | $2.53B | $2.53B | $2.54B |
| Accounts payable | $48.69M | $61.69M | $46.01M | $62.99M | $69.24M | $76.93M |
| Total current liabilities | $539.87M | $548.32M | $531.41M | $253.23M | $273.95M | $260.08M |
| Long-term debt | $919.99M | $920.39M | $920.83M | $1.22B | $1.22B | $1.22B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $381.09M | $336.32M | $356.05M | $392.23M | $368.54M | $386.64M |
| Total equity | $911.45M | $849.17M | $882.30M | $906.86M | $878.85M | $905.37M |